BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 37718413)

  • 1. Cyclin-dependent kinases: Masters of the eukaryotic universe.
    Pluta AJ; Studniarek C; Murphy S; Norbury CJ
    Wiley Interdiscip Rev RNA; 2023 Sep; 15(1):e1816. PubMed ID: 37718413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional cyclin-dependent kinases as the mediators of inflammation-a review.
    Sundar V; Vimal S; Sai Mithlesh MS; Dutta A; Tamizhselvi R; Manickam V
    Gene; 2021 Feb; 769():145200. PubMed ID: 33031895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.
    Chiu HC; Huang WR; Liao TL; Chi PI; Nielsen BL; Liu JH; Liu HJ
    J Biol Chem; 2018 Aug; 293(32):12542-12562. PubMed ID: 29907572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CDK/cyclin complexes in transcription and RNA splicing.
    Loyer P; Trembley JH; Katona R; Kidd VJ; Lahti JM
    Cell Signal; 2005 Sep; 17(9):1033-51. PubMed ID: 15935619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinases.
    Malumbres M
    Genome Biol; 2014; 15(6):122. PubMed ID: 25180339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pause, play, repeat: CDKs push RNAP II's buttons.
    Sansó M; Fisher RP
    Transcription; 2013; 4(4):146-52. PubMed ID: 23756342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the development of selective small molecule inhibitors for cyclin-dependent kinases.
    Hirai H; Kawanishi N; Iwasawa Y
    Curr Top Med Chem; 2005; 5(2):167-79. PubMed ID: 15853645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of CDK/Cyclin complexes in transcription and pre-mRNA splicing: Cyclins L and CDK11 at the cross-roads of cell cycle and regulation of gene expression.
    Loyer P; Trembley JH
    Semin Cell Dev Biol; 2020 Nov; 107():36-45. PubMed ID: 32446654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
    Roskoski R
    Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy.
    Chou J; Quigley DA; Robinson TM; Feng FY; Ashworth A
    Cancer Discov; 2020 Mar; 10(3):351-370. PubMed ID: 32071145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
    Roskoski R
    Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging roles of the CDK/cyclin complexes in antiviral innate immunity.
    Zheng C; Tang YD
    J Med Virol; 2022 Jun; 94(6):2384-2387. PubMed ID: 34964486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.
    Ravitz MJ; Wenner CE
    Adv Cancer Res; 1997; 71():165-207. PubMed ID: 9111866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinase pathways as targets for cancer treatment.
    Shapiro GI
    J Clin Oncol; 2006 Apr; 24(11):1770-83. PubMed ID: 16603719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CDK Network: Linking Cycles of Cell Division and Gene Expression.
    Fisher RP
    Genes Cancer; 2012 Nov; 3(11-12):731-8. PubMed ID: 23634260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian interphase cdks: dispensable master regulators of the cell cycle.
    Enders GH
    Genes Cancer; 2012 Nov; 3(11-12):614-8. PubMed ID: 23634250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma.
    Liao Y; Feng Y; Shen J; Hornicek FJ; Duan Z
    Cancer Metastasis Rev; 2016 Jun; 35(2):151-63. PubMed ID: 26669603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone acetylation and the cell-cycle in cancer.
    Wang C; Fu M; Mani S; Wadler S; Senderowicz AM; Pestell RG
    Front Biosci; 2001 Apr; 6():D610-29. PubMed ID: 11282573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-dependent kinase inhibitors: novel anticancer agents.
    Mani S; Wang C; Wu K; Francis R; Pestell R
    Expert Opin Investig Drugs; 2000 Aug; 9(8):1849-70. PubMed ID: 11060782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts in neuro-oncology: the cell cycle--a review.
    Dirks PB; Rutka JT
    Neurosurgery; 1997 May; 40(5):1000-13; discussion 1013-5. PubMed ID: 9149259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.